Jacqueline E Deutscher, CRNA | |
3288 Moanalua Rd, Honolulu, HI 96819-1469 | |
(808) 432-0000 | |
Not Available |
Full Name | Jacqueline E Deutscher |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 18 Years |
Location | 3288 Moanalua Rd, Honolulu, Hawaii |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952420176 | NPI | - | NPPES |
59547301 | Medicaid | HI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | RN-59703 (Hawaii) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fdhs Anesthesia Llc | 2365854718 | 19 |
News Archive
The federal government on Thursday issued rules on the federal benefits that gay Americans and their same-sex spouses can expect to receive. HHS said Medicare will allow all beneficiaries access to care in a nursing home where their spouse lives.
The study, by Dr Rob Hester from the Department of Psychological Sciences and colleagues at the Queensland Brain Institute, investigated how the brain monitors ongoing behavior for performance errors – specifically failures of impulse control. This study found that a single dose of methylphenidate (Ritalin) results in significantly greater activity in the brain's error monitoring network and improved volunteers' awareness of their mistakes.
The death rate among patients prescribed a statin in a major trial that ended in 2003 is still lower than those given a placebo, even though most participants in both groups have been taking statins ever since. ASCOT, the Anglo-Scandinavian Cardiac Outcomes Trial, was stopped early because the statin was so effective at preventing heart attacks and strokes, but a new analysis has shown that eight years on, the most significant difference between the groups is a reduction in deaths from infection and respiratory illness.
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
› Verified 1 days ago
Entity Name | Anesthesia Dynamics Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20190820001117 |
News Archive
The federal government on Thursday issued rules on the federal benefits that gay Americans and their same-sex spouses can expect to receive. HHS said Medicare will allow all beneficiaries access to care in a nursing home where their spouse lives.
The study, by Dr Rob Hester from the Department of Psychological Sciences and colleagues at the Queensland Brain Institute, investigated how the brain monitors ongoing behavior for performance errors – specifically failures of impulse control. This study found that a single dose of methylphenidate (Ritalin) results in significantly greater activity in the brain's error monitoring network and improved volunteers' awareness of their mistakes.
The death rate among patients prescribed a statin in a major trial that ended in 2003 is still lower than those given a placebo, even though most participants in both groups have been taking statins ever since. ASCOT, the Anglo-Scandinavian Cardiac Outcomes Trial, was stopped early because the statin was so effective at preventing heart attacks and strokes, but a new analysis has shown that eight years on, the most significant difference between the groups is a reduction in deaths from infection and respiratory illness.
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
› Verified 1 days ago
Entity Name | Fdhs Anesthesia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619571361 PECOS PAC ID: 2365854718 Enrollment ID: O20201209001867 |
News Archive
The federal government on Thursday issued rules on the federal benefits that gay Americans and their same-sex spouses can expect to receive. HHS said Medicare will allow all beneficiaries access to care in a nursing home where their spouse lives.
The study, by Dr Rob Hester from the Department of Psychological Sciences and colleagues at the Queensland Brain Institute, investigated how the brain monitors ongoing behavior for performance errors – specifically failures of impulse control. This study found that a single dose of methylphenidate (Ritalin) results in significantly greater activity in the brain's error monitoring network and improved volunteers' awareness of their mistakes.
The death rate among patients prescribed a statin in a major trial that ended in 2003 is still lower than those given a placebo, even though most participants in both groups have been taking statins ever since. ASCOT, the Anglo-Scandinavian Cardiac Outcomes Trial, was stopped early because the statin was so effective at preventing heart attacks and strokes, but a new analysis has shown that eight years on, the most significant difference between the groups is a reduction in deaths from infection and respiratory illness.
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jacqueline E Deutscher, CRNA 3288 Moanalua Rd, Honolulu, HI 96819-1469 Ph: (808) 432-0000 | Jacqueline E Deutscher, CRNA 3288 Moanalua Rd, Honolulu, HI 96819-1469 Ph: (808) 432-0000 |
News Archive
The federal government on Thursday issued rules on the federal benefits that gay Americans and their same-sex spouses can expect to receive. HHS said Medicare will allow all beneficiaries access to care in a nursing home where their spouse lives.
The study, by Dr Rob Hester from the Department of Psychological Sciences and colleagues at the Queensland Brain Institute, investigated how the brain monitors ongoing behavior for performance errors – specifically failures of impulse control. This study found that a single dose of methylphenidate (Ritalin) results in significantly greater activity in the brain's error monitoring network and improved volunteers' awareness of their mistakes.
The death rate among patients prescribed a statin in a major trial that ended in 2003 is still lower than those given a placebo, even though most participants in both groups have been taking statins ever since. ASCOT, the Anglo-Scandinavian Cardiac Outcomes Trial, was stopped early because the statin was so effective at preventing heart attacks and strokes, but a new analysis has shown that eight years on, the most significant difference between the groups is a reduction in deaths from infection and respiratory illness.
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
› Verified 1 days ago
Peter Loving, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-691-1000 | |
Debra J Brittain, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Cynthia K. Poe, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Diane Martelli, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-547-4929 Fax: 808-547-4044 | |
Ms. Jessica Hammonds Deery, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Lauren Rebecca Ellis James, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Anna P. Doyle, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 |